Survival feature and trend of female breast cancer: A comprehensive review of survival analysis from cancer registration data
- PMID: 39701013
- PMCID: PMC11722932
- DOI: 10.1016/j.breast.2024.103862
Survival feature and trend of female breast cancer: A comprehensive review of survival analysis from cancer registration data
Abstract
To better understand global patterns, chronological changes, and international comparisons of female breast cancer survival, we reviewed published data from population-based cancer registries worldwide. Using PubMed, Embase, Web of Science, SEER, and SinoMed, a comprehensive literature search was conducted for female breast cancer survival from the population-based cancer registries through 31 December 2023. Observed, relative, and net survival rates and their corresponding age-standardized survival rates since the 1990s were collected and further stratified by prognostic factors. The prognosis of female breast cancer patients was favorable, with 5-year relative survival rates above 80 % in most regions. The trend in breast cancer survival showed annual increases in most countries but was accompanied by geographical disparities. The highest age-standardized 5-year relative survival rate was identified in the USA (2010-2014) at 90.2 %, while the lowest was in India (2010-2014) at 66.1 %. Overall, North America and Oceania had the best survival, and, for Europe, survival was worst in Eastern Europe. The survival in some Asian countries was disturbing. Younger age groups had a better prognosis than those aged 75 years and over. The lowest survival rates were observed in patients with distant metastatic and triple-negative breast cancer. Worldwide, there has been a steady improvement in female breast cancer survival. However, the survival gap between developed and developing countries has remained wide over the past 30 years. Differences in age, stage at diagnosis, and molecular subtype may explain some of the disparities, providing evidence for targeted management strategies.
Keywords: Cancer registry; Female breast cancer; Observed survival rate; Relative survival rate; Time trend.
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest All authors declared that there are no conflicts of interest.
Figures




Similar articles
-
Changes in Esophageal Cancer Survival: A Global Review of Survival Analysis from Cancer Registration Data over the Past Three Decades.Biomed Environ Sci. 2025 May 20;38(5):571-584. doi: 10.3967/bes2025.018. Biomed Environ Sci. 2025. PMID: 40506379 Review.
-
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748
-
Global Trend of Breast Cancer Mortality Rate: A 25-Year Study.Asian Pac J Cancer Prev. 2019 Jul 1;20(7):2015-2020. doi: 10.31557/APJCP.2019.20.7.2015. Asian Pac J Cancer Prev. 2019. PMID: 31350959 Free PMC article.
-
Italian cancer figures, report 2012: Cancer in children and adolescents.Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. Epidemiol Prev. 2013. PMID: 23585445 English, Italian.
-
Cancer of the Nasal Cavity, Middle Ear and Accessory Sinuses - 15 Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and Topographic Primary Sites: A Systematic Review of 13,404 Cases for Diagnosis Years 2000-2017: (NCI SEER*Stat 8.3.8).J Insur Med. 2024 Jul 1;51(2):77-91. doi: 10.17849/insm-51-2-77-91.1. J Insur Med. 2024. PMID: 39266003
Cited by
-
Triple-Negative Breast Cancer on the Rise: Breakthroughs and Beyond.Breast Cancer (Dove Med Press). 2025 Jun 26;17:523-529. doi: 10.2147/BCTT.S516125. eCollection 2025. Breast Cancer (Dove Med Press). 2025. PMID: 40599557 Free PMC article. Review.
-
Dual role of lncRNA OTUD6B-AS1 in immune evasion and ferroptosis resistance: A prognostic and therapeutic biomarker in breast cancer.Noncoding RNA Res. 2025 Jun 17;14:156-165. doi: 10.1016/j.ncrna.2025.06.002. eCollection 2025 Oct. Noncoding RNA Res. 2025. PMID: 40678154 Free PMC article.
-
Bibliometric analysis and visualization of Connexin 43 in the field of solid tumor research(2000-2024).Front Immunol. 2025 May 9;16:1588828. doi: 10.3389/fimmu.2025.1588828. eCollection 2025. Front Immunol. 2025. PMID: 40416989 Free PMC article.
-
Improvement in breast cancer survival across molecular subtypes in Hungary between 2011 and 2020: a nationwide, retrospective study.Front Oncol. 2025 Mar 31;15:1465511. doi: 10.3389/fonc.2025.1465511. eCollection 2025. Front Oncol. 2025. PMID: 40231260 Free PMC article.
-
Clinical Utility of Integrated Multidisciplinary Patient-Centered Information in Breast Cancer Care: A Mixed Methods Study.J Multidiscip Healthc. 2025 Apr 5;18:1875-1893. doi: 10.2147/JMDH.S506292. eCollection 2025. J Multidiscip Healthc. 2025. PMID: 40206653 Free PMC article.
References
-
- Allemani C., Matsuda T., Di Carlo V., et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075. doi: 10.1016/s0140-6736(17)33326-3. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous